RSB Spine, LLC, Announces Record Second-Quarter 2011 Revenue

Dienstag, 5. Juli 2011

CLEVELAND – July 5, 2011 – RSB Spine, LLC, a medical device company focused on developing unique modular fusion products for surgical treatment of degenerative disc disease, today announced a 131% sales increase for the second quarter of 2011 versus second quarter 2010, and a 20% increase sequentially. These record results represent the seventh consecutive sequential period of quarterly growth for the company.


 RSB Spine Chief Executive Officer John A. Redmond said: “Our performance this quarter is especially gratifying given the challenges facing the spinal implant market, with price erosion and reimbursement pushback from insurance companies.  It is a testament to our superior product offering and distribution.”


“We are very excited with the rapid expansion of our product portfolio including the addition of allograft bone,” said Mike O’Neill, CEO of Paradigm Biodevices.  “Our surgeon customers are very excited by the unique options our modular implants offer their patients, reinforcing our continuing portfolio expansion.”


RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at:


Paradigm BioDevices, Inc. is a privately held Boston-based medical device distributor.   News releases and other information on the company are available at




John A. Redmond

Chief Executive Officer


Email Address